WELL Health Technologies Corp
TSX:WELL
P/OCF
Price to OCF
Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.
Market Cap | P/OCF | ||||
---|---|---|---|---|---|
CA |
WELL Health Technologies Corp
TSX:WELL
|
922.3m CAD | 14 | ||
US |
C
|
Cigna Group
XMUN:CGN
|
92.4B EUR | 8.6 | |
US |
Cigna Corp
NYSE:CI
|
98.5B USD | 8.5 | ||
US |
CVS Health Corp
NYSE:CVS
|
70.1B USD | 6.4 | ||
US |
Laboratory Corporation of America Holdings
NYSE:LH
|
17.8B USD | 15.1 | ||
DE |
Fresenius SE & Co KGaA
XETRA:FRE
|
16.1B EUR | 3.7 | ||
US |
Quest Diagnostics Inc
NYSE:DGX
|
15.4B USD | 11.6 | ||
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
12B EUR | 4.6 | |
DE |
Fresenius Medical Care AG
XMUN:FME
|
11.8B EUR | 4.5 | ||
US |
DaVita Inc
NYSE:DVA
|
12B USD | 8.2 | ||
US |
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | -30.6 |
P/OCF Forward Multiples
Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.